Details for Patent: 8,748,481
✉ Email this page to a colleague
Which drugs does patent 8,748,481 protect, and when does it expire?
Patent 8,748,481 protects AMITIZA and is included in one NDA.
This patent has twenty-nine patent family members in seventeen countries.
Summary for Patent: 8,748,481
Title: | Method for treating gastrointestinal disorder |
Abstract: | The present invention relates to a method for the long term treatment of gastrointestinal disorders in a human subject, which comprises administering an effective amount of a halogenated prostaglandin compound and/or its tautomer to the subject. The method induces substantially no electrolyte shifting during the term of the treatment. The compound used in the present invention can improve quality of life in the human subjects with gastrointestinal disorders, are similarly effective in treating male and female subjects, and also effective in a human subject aged even 65 years and older. |
Inventor(s): | Ueno; Ryuji (Montgomery, MD) |
Assignee: | Sucampo AG (Zug, CH) |
Application Number: | 11/216,012 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,748,481 |
Patent Claim Types: see list of patent claims | Use; Delivery; Composition; |
Drugs Protected by US Patent 8,748,481
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD FOR THE LONG TERM TREATMENT OF CHRONIC CONSTIPATION IN A HUMAN SUBJECT WITH IRRITABLE BOWEL SYNDROME | ⤷ Sign Up | |||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD FOR THE LONG TERM TREATMENT OF CHRONIC CONSTIPATION IN A HUMAN SUBJECT | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,748,481
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 050626 | ⤷ Sign Up | |||
Argentina | 107905 | ⤷ Sign Up | |||
Australia | 2005278323 | ⤷ Sign Up | |||
Brazil | PI0514891 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |